<DOC>
	<DOCNO>NCT01585792</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety treatment TAK-875 diabetic patient .</brief_summary>
	<brief_title>Double Blind Comparative Study TAK-875</brief_title>
	<detailed_description />
	<mesh_term>Glimepiride</mesh_term>
	<criteria>The participant outpatient . The participant sign date write , informed consent form require privacy authorization prior initiation study procedure . The participant serious cardiac disease , serious cerebrovascular disorder , serious pancreatic hematological disease . The participant consider ineligible study reason investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>